BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/6/2026 8:34:25 AM | Browse: 5 | Download: 8
 |
Received |
|
2025-12-11 01:25 |
|
Peer-Review Started |
|
2025-12-11 01:25 |
|
First Decision by Editorial Office Director |
|
2026-01-23 09:24 |
|
Return for Revision |
|
2026-01-23 09:24 |
|
Revised |
|
2026-02-02 03:48 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-03-03 02:40 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-03 07:08 |
|
Articles in Press |
|
2026-03-03 07:08 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-04-21 01:00 |
|
Publish the Manuscript Online |
|
2026-05-06 08:34 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Correspondence |
| Article Title |
Letter to the Editor: Leucine-rich α-2-glycoprotein in Taiwanese inflammatory bowel disease: Strengths and limitations of a novel serum marker
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rupa Guha and Aditi Banerjee |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Aditi Banerjee, Associate Professor, Department of Pediatrics, University of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, MD 21201, United States. aditi.banerjee@som.umaryland.edu |
| Key Words |
Leucine-rich α2 glycoprotein; Inflammatory bowel disease; Ulcerative colitis; Crohn’s disease; Endoscopic activity; Serum biomarker; Fecal calprotectin |
| Core Tip |
Leucine-rich α-2-glycoprotein (LRG) is an emerging serum biomarker that showed modest but incremental value for predicting endoscopic activity in Taiwanese patients with ulcerative colitis and Crohn’s disease, particularly when combined with C-reactive protein, hemoglobin, and albumin. This Letter highlights methodological issues and clinical implications of LRG testing, including its lower accuracy than fecal calprotectin, single-center data, and lack of standardized cutoffs, and argues that future multicenter, multi-ethnic studies should position LRG within composite biomarker panels and stepwise algorithms for noninvasive assessment of inflammatory bowel disease activity. |
| Publish Date |
2026-05-06 08:34 |
| Citation |
Guha R, Banerjee A. Letter to the Editor: Leucine-rich α-2-glycoprotein in Taiwanese inflammatory bowel disease: Strengths and limitations of a novel serum marker. World J Gastroenterol 2026; 32(18): 117611 |
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i18/117611.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i18.117611 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
